Spero Therapeutics to Present Data at IDWeek 2021

CAMBRIDGE, Mass., Sept. 16, 2021 (Globalrelease Wire) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing treatments in high unmet need areas involving …